Drug Trial Radar · NCT06556368
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
667
Actual
Start
Aug 23, 2024
Primary completion
Sep 2, 2026
Study completion Aug 2027
Sponsor
- Lead sponsor
- Kodiak Sciences IncIndustry
- Sponsor type
- Industry
- First posted
- Aug 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD)
Conditions
- Wet Age-related Macular Degeneration
Interventions
Tarcocimab tedromerDrug
Intravitreal injection
Tabirafusp tedromerDrug
Intravitreal injection
AfliberceptDrug
Intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Best corrected visual acuity (BCVA)Time frame: Week 48
Locations
72 sites in 2 countries. Site status is shown where the registry gives one.
Associated Retina Consultants
Gilbert, Arizona
Associated Retina Consultants
Phoenix, Arizona
Retina Macula Institute of Arizona
Scottsdale, Arizona
Retina Associates SW
Tucson, Arizona
Retina Consultants of Orange County
Fullerton, California
Global Research Management, Inc. - Lugene Eye Institute
Glendale, California
Retinal Consultants Medical Group, Inc.
Modesto, California
California Eye Specialists Medical Group, Inc.
Pasadena, California
California Eye Specialists Medical Group, Inc.
Redlands, California
Retinal Consultants Medical Group Inc
Sacramento, California
Retina Consultants of Southern Colorado
Colorado Springs, Colorado
Retina Group of New England, PC
Waterford, Connecticut
Blue Ocean Clinical Research
Clearwater, Florida
Retina Group of Florida
Fort Lauderdale, Florida
National Ophthalmic Research Institute
Fort Myers, Florida
Retina Group of Florida
Sarasota, Florida
Center for Retina and Macular Disease
Winter Haven, Florida
Southeast Retina Center
Augusta, Georgia
Retina Associates, Ltd
Elmhurst, Illinois
Illinois Retina Associates
Oak Park, Illinois
Associated Vitreoretinal and Uveitis Consultants LLC
Carmel, Indiana
Midwest Eye Institute
Carmel, Indiana
The Retina Care Center
Baltimore, Maryland
Cumberland Valley Retina Consultants
Hagerstown, Maryland
Ophthalmic Consultants of Boston
Boston, Massachusetts
Retina Consultants of Minnesota
Edina, Minnesota
Retina Consultants of Minnesota
Saint Louis Park, Minnesota
Mississippi Retina Associates
Madison, Mississippi
The Retina Institute
St Louis, Missouri
Retina Consultants of Nevada
Henderson, Nevada
Long Island Vitreoretinal Consultants
Hauppauge, New York
Retina Vitreous Surgeons of CNY PC
Liverpool, New York
Retina Associates of Western NY
Rochester, New York
Asheville Eye Associates
Asheville, North Carolina
North Carolina Retina Associates
Cary, North Carolina
Piedmont Retina Specialist
Greensboro, North Carolina
Graystone Eye
Hickory, North Carolina
North Carolina Retina Associates
Wake Forest, North Carolina
Western Carolina Clinical Research, LLC
Winston-Salem, North Carolina
Retina Northwest
Portland, Oregon
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.